Venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL)
Rapid Review
| Commenced | Completed | Outcome |
| 03/01/2017 | 08/02/2017 | Full HTA not recommended until further evidence available |
Venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL)
Rapid Review
| Commenced | Completed | Outcome |
| 03/01/2017 | 08/02/2017 | Full HTA not recommended until further evidence available |